ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
Snyder, James; Wells, Michael; Poisson, Laila; Kalkanis, Steven; Noushmehr, Houtan ; Robin, Adam
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: ENSAIO CLÍNICO, MENINGIOMA, GLÂNDULA PITUITÁRIA, NEOPLASIAS CEREBRAIS, ASTROCITOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 10 maio 2024. , 2019
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Trabalho de evento-resumo periodico
Active transcription start sites of meningioma samples associated with risk of recurrence (2019)
Malta, Tathiane; Sabedot, Thais Sarra; Carlotti Júnior, Carlos Gilberto ; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: TRANSCRIÇÃO GÊNICA, MENINGIOMA, NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.460. Acesso em: 10 maio 2024. , 2019
APA
Malta, T., Sabedot, T. S., Carlotti Júnior, C. G., & Noushmehr, H. (2019). Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.460
NLM
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Vancouver
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 10 maio 2024. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 10 maio 2024. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Methylation-based liquid biopsy of meningioma primary and recurrent samples (2019)
Sabedot, Thais Sarraf; Malta, Tathiane; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Anavaleria; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: MENINGIOMA, NEOPLASIAS CEREBRAIS, BIÓPSIA, BIOMARCADORES, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.463. Acesso em: 10 maio 2024. , 2019
APA
Sabedot, T. S., Malta, T., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2019). Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.463
NLM
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Vancouver
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Trabalho de evento-resumo
Epigenome analysis of pituitary adenomas define candidate master regulators (2019)
Mosella, Maritza Queiroz Salas ; Felicella, Michelle; Aho, Todd; Noushmehr, Houtan ; Castro, Ana Valeria de; Sabedot, Thais; Malta, Tathiane; Rock, Jack
Source: Programme Book. Conference titles: Conference Cancer Genomics. Unidade: FMRP
Subjects: ADENOMA, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. Epigenome analysis of pituitary adenomas define candidate master regulators. 2019, Anais.. Cambridge: European Association for Cancer Research, 2019. . Acesso em: 10 maio 2024.
APA
Mosella, M. Q. S., Felicella, M., Aho, T., Noushmehr, H., Castro, A. V. de, Sabedot, T., et al. (2019). Epigenome analysis of pituitary adenomas define candidate master regulators. In Programme Book. Cambridge: European Association for Cancer Research.
NLM
Mosella MQS, Felicella M, Aho T, Noushmehr H, Castro AV de, Sabedot T, Malta T, Rock J. Epigenome analysis of pituitary adenomas define candidate master regulators. Programme Book. 2019 ;[citado 2024 maio 10 ]
Vancouver
Mosella MQS, Felicella M, Aho T, Noushmehr H, Castro AV de, Sabedot T, Malta T, Rock J. Epigenome analysis of pituitary adenomas define candidate master regulators. Programme Book. 2019 ;[citado 2024 maio 10 ]
Trabalho de evento-resumo periodico
Epigenomic glioma subtype evaluation across 31 tumor types (2017)
Mosella, Maritza; Sarraf, Thais; Malta, Tathiane; Chedraoui, Tiago; Noushmehr, Houtan; Castro, Ana Valéria
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza et al. Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 10 maio 2024. , 2017
APA
Mosella, M., Sarraf, T., Malta, T., Chedraoui, T., Noushmehr, H., & Castro, A. V. (2017). Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
PD-L1 expression associated with glioma molecular subtypes: clinical implications (2017)
Malta, Tathiane; Snyder, James; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 10 maio 2024. , 2017
APA
Malta, T., Snyder, J., Kalkanis, S., Castro, A. V., & Noushmehr, H. (2017). PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype (2017)
Sabedot, Thais Sarraf; Poisson, Laila; Carvalho, Ana C. de; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 10 maio 2024. , 2017
APA
Sabedot, T. S., Poisson, L., Carvalho, A. C. de, & Noushmehr, H. (2017). Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/nox168

USP Schools

ReP

Filtros

Authors

Subjects